| Literature DB >> 33471172 |
Katja Evert1, Thomas Dienemann2, Christoph Brochhausen3, Dirk Lunz4, Matthias Lubnow5, Markus Ritzka2, Felix Keil3, Matthias Trummer3, Alexander Scheiter3, Bernd Salzberger6, Udo Reischl7, Peter Boor8, André Gessner7, Jonathan Jantsch7, Diego F Calvisi3, Matthias Evert3, Barbara Schmidt7, Michaela Simon7.
Abstract
Between April and June 2020, i.e., during the first wave of pandemic coronavirus disease 2019 (COVID-19), 55 patients underwent long-term treatment in the intensive care unit at the University Hospital of Regensburg. Most of them were transferred from smaller hospitals, often due to the need for an extracorporeal membrane oxygenation system. Autopsy was performed in 8/17 COVID-19-proven patients after long-term treatment (mean: 33.6 days). Autopsy revealed that the typical pathological changes occurring during the early stages of the disease (e.g., thrombosis, endothelitis, capillaritis) are less prevalent at this stage, while severe diffuse alveolar damage and especially coinfection with different fungal species were the most conspicuous finding. In addition, signs of macrophage activation syndrome was detected in 7 of 8 patients. Thus, fungal infections were a leading cause of death in our cohort of severely ill patients and may alter clinical management of patients, particularly in long-term periods of treatment.Entities:
Keywords: Autopsy; COVID-19; Fungal infection; Macrophage activation syndrome; Mycosis
Mesh:
Year: 2021 PMID: 33471172 PMCID: PMC7816067 DOI: 10.1007/s00428-020-03014-0
Source DB: PubMed Journal: Virchows Arch ISSN: 0945-6317 Impact factor: 4.064